Long-term follow-up for AB-1005 study participants
Part of Brain & nervous system clinical trials.
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease or multiple system atrophy (the parkinsonian type)
- You were enrolled in a previous study testing AB-1005
- You agree to take part and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who previously received IPS101A, an experimental gene therapy treatment for severe Parkinson's disease. Researchers want to check how you're doing over time and gather information about the treatment's long-term effects.
This study follows up with people who previously received an experimental treatment called RGL-193 for Parkinson's disease. It aims to check how safe and effective the treatment is over a longer period.
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
This study follows people with Parkinson's disease who are starting a second-line treatment — like deep brain stimulation, an apomorphine pump, or a duodopa pump — to see how these treatments work over time and how they affect daily life.
This study is collecting information from patients with multiple system atrophy (a rare neurological condition affecting movement and body functions), Parkinson disease, and healthy volunteers to better understand these conditions. By participating, you help doctors learn more about how these diseases develop and progress.
This study looks at how changing certain factors over time relates to symptoms in Parkinson’s disease and related conditions. You may help researchers by completing longer online surveys every 6 months for 5 years.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.